AR032052A1 - Polimero lineal de bloques, procedimiento para su preparacion, su uso, implantes, material para relleno, composiciones farmaceuticas y material polimerico poroso que comprenden dicho polimero lineal de bloques - Google Patents

Polimero lineal de bloques, procedimiento para su preparacion, su uso, implantes, material para relleno, composiciones farmaceuticas y material polimerico poroso que comprenden dicho polimero lineal de bloques

Info

Publication number
AR032052A1
AR032052A1 ARP010106033A ARP010106033A AR032052A1 AR 032052 A1 AR032052 A1 AR 032052A1 AR P010106033 A ARP010106033 A AR P010106033A AR P010106033 A ARP010106033 A AR P010106033A AR 032052 A1 AR032052 A1 AR 032052A1
Authority
AR
Argentina
Prior art keywords
linear block
block polymer
different
same
implants
Prior art date
Application number
ARP010106033A
Other languages
English (en)
Original Assignee
Artimplant Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004924A external-priority patent/SE518273C2/sv
Priority claimed from SE0100735A external-priority patent/SE0100735D0/xx
Application filed by Artimplant Ab filed Critical Artimplant Ab
Publication of AR032052A1 publication Critical patent/AR032052A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
    • C08G18/4269—Lactones
    • C08G18/4277—Caprolactone and/or substituted caprolactone
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/77—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur
    • C08G18/78—Nitrogen
    • C08G18/79—Nitrogen characterised by the polyisocyanates used, these having groups formed by oligomerisation of isocyanates or isothiocyanates
    • C08G18/797—Nitrogen characterised by the polyisocyanates used, these having groups formed by oligomerisation of isocyanates or isothiocyanates containing carbodiimide and/or uretone-imine groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2101/00—Manufacture of cellular products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)

Abstract

La presente se refiere a un polímero lineal de bloques, con un peso molecular de al menos 104 Dalton, que está compuesto de secuencias lineales internamente conectadas conforme a la formula (1), en la cual 1 a 100% de R1, en que los R1 de dicho 1 a 100% pueden ser iguales o distintos entre sí, comprenden un grupo funcional Z, pudiendo dichos Z ser iguales o distintos entre sí, y cada Z representa un grupo funcional protegido o no protegido, elegido entre hidroxilo, amino, carboxilo, tiol, ciano o nitro, y cada R2, pudiendo dichos R2 ser iguales o distintos entre sí puede estar derivado de un diisocianato y comprende ninguno, uno o más grupos éster; cada R3, pudiendo dichos R3 ser iguales o distintos entre sí, comprende ninguno, uno o más grupos éster y puede estar derivado de uno o más de los compuestos poliesterdiol, poliéterdiol o monodiol, procedimiento para preparacion y precipitacion fraccionada, implantes, material para promocion de curacion de heridas, composiciones farmacéuticas, microencapsulados, suspensiones y emulsiones.
ARP010106033A 2000-12-29 2001-12-26 Polimero lineal de bloques, procedimiento para su preparacion, su uso, implantes, material para relleno, composiciones farmaceuticas y material polimerico poroso que comprenden dicho polimero lineal de bloques AR032052A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0004924A SE518273C2 (sv) 2000-12-29 2000-12-29 Biologiskt nedbrytbar linjär blockpolymer, lämplig som material i implantat m m.
SE0100735A SE0100735D0 (sv) 2001-03-02 2001-03-02 Linjär blockpolymer

Publications (1)

Publication Number Publication Date
AR032052A1 true AR032052A1 (es) 2003-10-22

Family

ID=26655355

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010106033A AR032052A1 (es) 2000-12-29 2001-12-26 Polimero lineal de bloques, procedimiento para su preparacion, su uso, implantes, material para relleno, composiciones farmaceuticas y material polimerico poroso que comprenden dicho polimero lineal de bloques

Country Status (8)

Country Link
US (1) US20040106763A1 (es)
EP (1) EP1353968B1 (es)
JP (1) JP2004526003A (es)
CN (1) CN1518567A (es)
AR (1) AR032052A1 (es)
AT (1) ATE345357T1 (es)
DE (1) DE60124590D1 (es)
WO (1) WO2002053617A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10243966A1 (de) * 2002-09-20 2004-04-01 Adiam Life Science Ag Verfahren zur Herstellung von biokompatiblen Polyurethanen
CA2725103C (en) * 2008-05-29 2016-05-24 Dsm Ip Assets B.V. Antimicrobial polymers and their uses
JP5746629B2 (ja) * 2008-10-10 2015-07-08 ポリアクティヴァ・プロプライエタリー・リミテッド 生分解性ポリマー−生物活性部分の複合体

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE505703C2 (sv) * 1995-12-15 1997-09-29 Polyrand Ab Linjär blockpolymer innefattande urea- och uretangrupper, förfarande för framställning av linjära blockpolymerer samt användning av blockpolymererna som implantat
US4237229A (en) * 1975-06-10 1980-12-02 W. R. Grace & Co. Immobilization of biological material with polyurethane polymers
US4195127A (en) * 1975-06-10 1980-03-25 W. R. Grace & Co. Process for immobilizing proteins
NL7706283A (nl) * 1977-06-08 1978-12-12 Akzo Nv Werkwijze voor het bekleden van een voorwerp uit een gevulkaniseerde polyalkeenrubber.
US4250267A (en) * 1977-11-10 1981-02-10 W. R. Grace & Co. Immobilized biological material
US4226935A (en) * 1978-08-07 1980-10-07 W. R. Grace & Co. Enzymatic diagnostic composition
US4371611A (en) * 1978-08-07 1983-02-01 W. R. Grace & Co. Enzymatic diagnostic composition
US4600652A (en) * 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
DE3620504A1 (de) * 1986-06-19 1987-12-23 Bayer Ag Verfahren zur herstellung von polyurethan(harnstoff)-schaumstoffen und entsprechende, amin-modifizierte schaumstoffe
US4743632A (en) * 1987-02-25 1988-05-10 Pfizer Hospital Products Group, Inc. Polyetherurethane urea polymers as space filling tissue adhesives
JPH024736A (ja) * 1988-06-22 1990-01-09 Hitachi Maxell Ltd ポリカーボネートポリオール、芳香族ポリカーボネートポリウレタン樹脂、コーティング材、キャストフィルム、磁気記録媒体
US5159051A (en) * 1991-05-09 1992-10-27 Becton, Dickinson And Company Biostable polyurethane
US5159050A (en) * 1991-05-09 1992-10-27 Becton, Dickinson And Company Polyurethane and medical article therefrom
US6040415A (en) * 1997-04-17 2000-03-21 Toyobo Co., Ltd. Biocompatible polymers
JPH11152322A (ja) * 1997-11-20 1999-06-08 Toyobo Co Ltd ポリウレタンウレア樹脂の製造方法
SE514064C2 (sv) * 1999-02-02 2000-12-18 Artimplant Dev Artdev Ab Film för medicinsk användning bestående av linjära blockpolymerer av polyuretaner samt förfarande för framställning av en sådan film

Also Published As

Publication number Publication date
DE60124590D1 (en) 2006-12-28
US20040106763A1 (en) 2004-06-03
CN1518567A (zh) 2004-08-04
EP1353968B1 (en) 2006-11-15
JP2004526003A (ja) 2004-08-26
EP1353968A1 (en) 2003-10-22
WO2002053617A1 (en) 2002-07-11
WO2002053617B1 (en) 2002-09-19
ATE345357T1 (de) 2006-12-15

Similar Documents

Publication Publication Date Title
BR0213655A (pt) Composição e método para o tratamento dos cabelos e uso do polìmero
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
ES2180938T3 (es) Donadores de oxido nitrico capaces de reducir la toxicidad de los farmacos.
BRPI0411071A (pt) sistemas de reticulação para polìmeros de hidroxila
ATE252919T1 (de) Zusammensetzungen und ihre verwendung zur verhütung von verklebungen zwischen körpergewebe
BR9708473B1 (pt) "composição base adequada para uso na formação de uma composição cosmética"
DE69033994D1 (de) Flüssige Polymerzusammensetzung und Verfahren zu ihrer Verwendung
BR0113989A (pt) Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
BRPI0110024B8 (pt) derivados de ecteinascidina antitumorais, composição farmacêutica que os compreende e uso dos mesmos
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
CO4930282A1 (es) Cicloalquilo lactama lactona y compuestos relacionados composiciones farmaceuticas que comprenden los mismos metodos para inhibir la liberacion del peptido -amiloide y/o su sintesis mediante el uso de dichos compuestos
AR024634A1 (es) Composicion farmaceutica estabilizada en forma liofilizada
BR9812944A (pt) Inibidores bicìclicos da cinase
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
BR9711045A (pt) Drogas de atua-Æo prolongada e composi-{es farmac-uticas compreendendo as mesmas
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
BR0316915A (pt) Composição de manocompósito, método para prepará-lo e seu uso
BR0111948A (pt) Composição para entrega de fator de crescimento hematopoiético
DE69925156D1 (de) Verfahren und zusammensetzungen zur behandlung von zellproliferationsstörungen
BRPI0511966A (pt) composições farmacêuticas contendo polietileno glicol tendo um peso molecular menor do que 600 daltons
BR9801133A (pt) Sistema de lâmpada de eletroluminescência em forma de kit
BR0007942A (pt) Composição no estado sólido, processo para a preparação da mesma, uso de uma composição, elemento de construção, e, construção
BR0003987A (pt) Composição laxativa
BR0013638A (pt) Novas moléculas semelhantes a interferon beta

Legal Events

Date Code Title Description
FB Suspension of granting procedure